MAbs (BMS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMAbs (BMS)
Drug Alias Namebeta lactamase MAb conjugates (BMS)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsMelanomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A